PXDNL
Basic information
Region (hg38): 8:51319577-51809445
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PXDNL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 10 | 23 | |||
missense | 92 | 11 | 21 | 124 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 3 | |||||
Total | 0 | 0 | 92 | 24 | 37 |
Variants in PXDNL
This is a list of pathogenic ClinVar variants found in the PXDNL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-51319895-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
8-51319919-A-C | not specified | Uncertain significance (Sep 22, 2023) | ||
8-51319927-G-T | PXDNL-related disorder | Benign (Oct 28, 2019) | ||
8-51319952-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
8-51319982-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
8-51319989-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
8-51319994-A-C | not specified | Uncertain significance (Dec 21, 2022) | ||
8-51320805-G-A | PXDNL-related disorder | Benign (May 21, 2018) | ||
8-51320821-C-T | not specified | Likely benign (Aug 26, 2022) | ||
8-51320828-C-T | not specified | Uncertain significance (Jun 23, 2021) | ||
8-51320847-T-G | not specified | Uncertain significance (Oct 10, 2023) | ||
8-51320848-C-T | PXDNL-related disorder | Benign (Oct 28, 2019) | ||
8-51320854-T-C | not specified | Uncertain significance (Sep 27, 2022) | ||
8-51320856-T-C | Likely benign (Mar 01, 2023) | |||
8-51320895-T-C | not specified | Uncertain significance (Aug 20, 2023) | ||
8-51339633-G-T | PXDNL-related disorder | Benign (Aug 20, 2019) | ||
8-51339745-T-G | PXDNL-related disorder | Benign (Dec 31, 2019) | ||
8-51339751-T-A | not specified | Uncertain significance (Apr 18, 2023) | ||
8-51339760-A-G | PXDNL-related disorder | Benign (Oct 28, 2019) | ||
8-51345869-A-T | PXDNL-related disorder | Benign (Feb 14, 2020) | ||
8-51345873-G-A | not specified | Uncertain significance (Apr 16, 2024) | ||
8-51345878-C-A | not specified | Uncertain significance (Apr 26, 2024) | ||
8-51345894-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
8-51345934-T-A | PXDNL-related disorder | Likely benign (Mar 01, 2022) | ||
8-51371877-A-C | not specified | Uncertain significance (Mar 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PXDNL | protein_coding | protein_coding | ENST00000356297 | 23 | 489868 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.20e-35 | 0.000245 | 119322 | 112 | 5236 | 124670 | 0.0217 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.197 | 840 | 824 | 1.02 | 0.0000493 | 9417 |
Missense in Polyphen | 289 | 274.21 | 1.0539 | 3355 | ||
Synonymous | 1.27 | 310 | 340 | 0.913 | 0.0000229 | 2914 |
Loss of Function | 0.929 | 58 | 66.2 | 0.877 | 0.00000377 | 733 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0450 | 0.0446 |
Ashkenazi Jewish | 0.0431 | 0.0427 |
East Asian | 0.00164 | 0.00161 |
Finnish | 0.00451 | 0.00447 |
European (Non-Finnish) | 0.0166 | 0.0164 |
Middle Eastern | 0.00164 | 0.00161 |
South Asian | 0.0693 | 0.0683 |
Other | 0.0169 | 0.0165 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform PMR1: Endonuclease selectively degrading some target mRNAs while they are engaged by translating ribosomes, among which albumin and beta-globin mRNAs. {ECO:0000269|PubMed:22543864}.;
Intolerance Scores
- loftool
- rvis_EVS
- 2.73
- rvis_percentile_EVS
- 98.95
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.177
- ghis
- 0.388
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- response to oxidative stress;hydrogen peroxide catabolic process;oxidation-reduction process;nucleic acid phosphodiester bond hydrolysis;cellular oxidant detoxification
- Cellular component
- extracellular space;cytoplasm
- Molecular function
- endonuclease activity;peroxidase activity;heme binding;metal ion binding